Pretreatment endoscopy - Pro & contra: Is endoscopy needed before treatment in all patients with gastroesophageal reflux disease?

Endoscopy

Volumn 38, Issue 3, 2006, Pages 276-278

  Vakil, N ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; COLONOSCOPY; DEVELOPED COUNTRY; DIAGNOSTIC PROCEDURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; NORTH AMERICA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SCREENING; WESTERN EUROPE;

BARRETT ESOPHAGUS; COST-BENEFIT ANALYSIS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 33645079371     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924984     Document Type: Review

References (24)

1. Pace F, Manes G, Conio M, Bianchi Porro G. Endoscopy is needed before treatment in all patients with gastroesophageal reflux disease. Endoscopy 2006; 38: 271-275
2. 2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2001; 4: CD002095
3. National Institute for Clinical Excellence. Dyspepsia: management of dyspepsia in adults in primary care. Clinical guideline 17. London: National Institute for Clinical Excellence, 2004 (www.nice.org.uk/CG017NICEguideline)
4. Spiegel BM, Ofman JJ, Woods K, Vakil N. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. Am J Gastroenterol 2003; 98: 86-97
5. Moayyedi P, Delaney BC, Vakil N et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127: 1329-1337
6. Vakil N. How valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2005; 22 (Suppl 1): 64-69
7. Veldhuyzen van Zanten SJ, Bradette M, Chiba N et al. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol 2005; 19: 285-303
8. Smith T, Verzola E, Mertz H. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors. Gastrointest Endosc 2003; 58: 9-13
9. Blustein P, Beck P, Meddings J et al. The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol 1998; 93: 2508-2512
10. McDougall N, Johnston B, Kee F et al. Natural history of reflux esophagitis: a 10-year follow-up of the effects on patient symptomatology and quality of life. Gut 1996; 38: 481-486
11. Isolauri J, Luostarinen M, Isolauri E et al. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92: 37-41
12. MacDonald CE, Wicks AC, Playford RJ. Final results from a 10-year cohort of patients undergoing surveillance for Barrett's esophagus: observational study. Br Med J 2000; 321: 1252-1255
13. Van der Burgh A, Dees J, Hop WCJ, van Blankenstein M. Esophageal cancer is an uncommon cause of death in patients with Barrett's esophagus. Gut 1996; 39: 5-8
14. Meining A, Ott R, Becker I et al. The Munich Barrett follow-up study: suspicion of Barrett's esophagus based on either endoscopy or histology only - what is the clinical significance? Gut 2004; 53: 1402-1407
15. Lagergren J, Ye W, Bergstrom R, Nyren O. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA 2000; 284: 961-962
16. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-1677
17. Inadomi JM, Sampliner R, Lagergren J et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 2003; 138: 176-186
18. Quadri A, Vakil N. Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia. Aliment Pharmacol Ther 2003; 17: 835-840
19. Johnston B, Guning J, Lewis S. Health care seeking by heartburn sufferers is associated with psychosocial factors. Am J Gastroenterol 1996; 91: 2500-2504
20. Shaheen NJ, Dulai GS, Ascher B et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastroenterol 2005; 100: 577-580
21. Locke GR 3rd, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-1556
22. Corder AP, Jones RH, Sadler GH et al. Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice. Br J Clin Pract 1996; 50: 245-248
23. Rantanen TK, Salo JA. Gastroesophageal reflux disease as a cause of death: analysis of fatal cases under conservative treatment. Scand J Gastroenterol 1999; 34: 229-233
24. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7-33